NCT00001009View on ClinicalTrials.gov

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1990

Conditions

HIV Infections

Interventions

DRUG

Dextran sulfate

Trial Locations (8)

10021

Mem Sloan - Kettering Cancer Ctr, New York

10025

Saint Luke's - Roosevelt Hosp Ctr, New York

20037

George Washington Univ Med Ctr, Washington D.C.

55455

Univ of Minnesota, Minneapolis

90033

Los Angeles County - USC Med Ctr, Los Angeles

90095

UCLA CARE Ctr, Los Angeles

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

01655

Univ of Massachusetts Med Ctr, Worcester

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001009 - A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC) | Biotech Hunter | Biotech Hunter